Carregant...
Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model
AIM: To clarify the mechanism of infliximab treatment in diabetic macular edema (DME) and to provide a new alternative therapy for DME. METHODS: Rats were randomly divided into the control group, the model group and the infliximab treatment group. A diabetic rat model was created. The concentration...
Guardat en:
| Publicat a: | Int J Ophthalmol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Journal of Ophthalmology Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733508/ https://ncbi.nlm.nih.gov/pubmed/29259899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2017.12.06 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|